Piermont Capital Management’s Exelixis EXEL Stock Holding History

Piermont Capital Management’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-33,630	Closed	-$724K	–	138
2018 Q2	$724K	Buy	33,630 +18,800	+127%	+$389K	0.22%	127
2018 Q1	$328K	Hold	14,830	–	–	0.11%	215
2017 Q4	$451K	Hold	14,830	–	–	0.15%	176
2017 Q3	$359K	Sell	14,830 -10,870	-42%	-$289K	0.12%	206
2017 Q2	$633K	Buy	+25,700	New	+$544K	0.18%	208
2017 Q1	–	Sell	-31,270	Closed	-$466K	–	257
2016 Q4	$466K	Hold	31,270	–	–	0.11%	231
2016 Q3	$400K	Buy	+31,270	New	+$338K	0.09%	241
2016 Q2	–	Sell	-97,250	Closed	-$389K	–	251
2016 Q1	$389K	Buy	97,250 +3,750	+4%	+$15.9K	0.12%	188
2015 Q4	$527K	Buy	+93,500	New	+$523K	0.17%	138

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Piermont Capital Management's EXEL Position: Q3 2018 in Review

Piermont Capital Management sold out of Exelixis (EXEL) in Q3 2018, closing a stake of 33,630 shares — an estimated $724K sold.

Piermont Capital Management first reported a position in EXEL in Q4 2015 and held it in 9 quarters. The position peaked at $724K in Q2 2018. 316 funds tracked by Wall St. Rank hold EXEL as of Q3 2018.

Piermont Capital Management reported no remaining Exelixis position as of Q3 2018 after selling out during the quarter.
Piermont Capital Management sold 33,630 Exelixis shares in Q3 2018, an estimated $724K.
Piermont Capital Management first reported a position in Exelixis in Q4 2015 and held it in 9 quarters.
Piermont Capital Management's Exelixis position peaked at $724K in Q2 2018.
316 funds tracked by Wall St. Rank held Exelixis as of Q3 2018.

Based on Piermont Capital Management's 13F filing for Q3 2018, filed 6 Nov 2018.